Your browser doesn't support javascript.
loading
Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine.
Liu, Zhigang; Alexander, James L; Lin, Kathy Weitung; Ahmad, Tariq; Pollock, Katrina M; Powell, Nick.
Afiliação
  • Liu Z; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Alexander JL; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom, and, Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Lin KW; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Ahmad T; Royal Devon University Healthcare NHS Foundation Trust, Exeter, United Kingdom.
  • Pollock KM; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Powell N; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom, and, Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, United Kingdom. Electronic address: npowell@imperial.ac.uk.
Gastroenterology ; 164(2): 300-303.e3, 2023 02.
Article em En | MEDLINE | ID: mdl-36270334
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infliximab / Inibidores de Janus Quinases / Vacinas contra COVID-19 Limite: Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infliximab / Inibidores de Janus Quinases / Vacinas contra COVID-19 Limite: Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido